Clinical Trial Update: Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation multi-arm trial evaluating MLN4924 (pevonedistat) with docetaxel, gemcitabine, or with carboplatin/paclitaxel in solid tumors; completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Gemcitabine (Gemcitabine)
• MLN4924 (pevonedistat)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2020-06-22